[图书][B] Little and Falace's Dental Management of the Medically Compromised Patient-E-Book: Little and Falace's Dental Management of the Medically Compromised …

C Miller, NL Rhodus, NS Treister, ET Stoopler, AR Kerr - 2023 - books.google.com
Little and Falace's Dental Management of the Medically Compromised Patient, 10th Edition,
is thoroughly revised to provide the information needed to assess common problems and …

Non-pyogenic infections of the spine

GS Skaf, ZA Kanafani, GF Araj, SS Kanj - International journal of …, 2010 - Elsevier
Subacute and chronic spondylodiscitis can be caused by a wide spectrum of infectious
aetiologies including Mycobacterium tuberculosis, Brucella spp. and a variety of fungi …

[HTML][HTML] Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010

M Zignol, W Gemert, D Falzon… - Bulletin of the world …, 2012 - SciELO Public Health
OBJECTIVE: To present a global update of drug-resistant tuberculosis (TB) and explore
trends in 1994-2010. METHODS: Data on drug resistance among new and previously …

[HTML][HTML] NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis

AK Pandey, Y Yang, Z Jiang, SM Fortune… - PLoS …, 2009 - journals.plos.org
While the recognition of microbial infection often occurs at the cell surface via Toll-like
receptors, the cytosol of the cell is also under surveillance for microbial products that breach …

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection …

R Sun, YAW Skeiky, A Izzo, V Dheenadhayalan… - Vaccine, 2009 - Elsevier
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), has infected
approximately two billion individuals worldwide with approximately 9.2 million new cases …

[HTML][HTML] A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury

C Luangchosiri, A Thakkinstian, S Chitphuk… - … and alternative medicine, 2015 - Springer
Background Hepatitis is a common adverse effect of antituberculosis drugs. Silymarin
prevented drug-induced hepatoxicity in animals with anti-oxidative mechanisms but its effect …

[HTML][HTML] Mycobacterium tuberculosis Rv3586 (DacA) Is a Diadenylate Cyclase That Converts ATP or ADP into c-di-AMP

Y Bai, J Yang, X Zhou, X Ding, LE Eisele, G Bai - PloS one, 2012 - journals.plos.org
Cyclic diguanosine monophosphate (c-di-GMP) and cyclic diadenosine monophosphate (c-
di-AMP) are recently identified signaling molecules. c-di-GMP has been shown to play …

Silencing Essential Protein Secretion in Mycobacterium smegmatis by Using Tetracycline Repressors

XV Guo, M Monteleone, M Klotzsche… - Journal of …, 2007 - Am Soc Microbiol
Many processes that are essential for mycobacterial growth are poorly understood. To
facilitate genetic analyses of such processes in mycobacteria, we and others have …

Nucleotide-Binding Oligomerization Domain Protein 2-Deficient Mice Control Infection with Mycobacterium tuberculosis

S Gandotra, S Jang, PJ Murray, P Salgame… - Infection and …, 2007 - Am Soc Microbiol
Nucleotide-binding oligomerization domain proteins (NODs) are modular cytoplasmic
proteins implicated in the recognition of peptidoglycan-derived molecules. NOD2 has …

[HTML][HTML] Tuberculosis in Saudi Arabia: can we change the way we deal with the disease?

SA Al-Hajoj - Journal of infection and public health, 2010 - Elsevier
Infection from Mycobacterium tuberculosis results in the death of three million people
worldwide per annum of which an estimated one thousand are in Saudi Arabia. The WHO …